VAT-free international shipments

State of the art health technologies

Affilates and B2B support

Prof. George Birkmayer NADH.

(2 Products)
Prof. George Birkmayer NADH.

NADH Research
The effect of NADH (Coenzym 1) on the human organism was first discovered by the Austrian scientist, Professor George Birkmayer, MD, PhD. He was the first and only to succeed in stabilizing NADH in tablet form and making it bioavailable for the human body. For his NADH formula he obtained more than 50 patents and is regarded internationally as the leading expert for NADH. The effect of his NADH formula has been documented in numerous studies. For medical staff we provide additional information such as publications and studies on the therapeutic effect of NADH. Curriculum. Professor Dr. med. Dr. chem. George D. Birkmayer, MD., PhD. (born 1941 in Vienna) has a doctorate in biochemistry as well as in medicine. He became Associate Professor for Cell Biology at the University of Munich in 1988 and Associate Professor for Medical Chemistry at the University of Graz (Austria). He is author of more than 150 scientific publications and obtains a strong international profile as visiting professor at the Universities in Beijing, Guangzhou, Xi'An, Cornell University (New York) and the American College of Nutrition. He holds world-wide lectures on his research in Oncology, Neurology and Anti-Aging Medicine. In 1999, he was invited to the Annual Denham Harman Lecture of the American Academy for the Advancement of Medicine. Since 1981 he has been a member of the New York Academy of Sciences and, since 2010, Honorary President of the International Academy for Targeted Therapy.

View as

Compare /8